-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Initiates Coverage On Palisade Bio with Buy Rating, Announces Price Target of $12

Benzinga·12/30/2025 17:06:54
Listen to the news
Clear Street analyst Kaveri Pohlman initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $12.